WARNER ROBINS, Ga. , Aug. 7, 2024 /PRNewswire/ -- Aquila Solutions, a regulatory and pharmaceutical management consulting leader, has launched Altair, an advanced eCTD (Electronic Common Technical Document) viewer.
The tool gives drug application sponsors the ability to view their regulatory submissions just as FDA reviewers view them. Altair allows sponsors to see how each sequence affects their application, to view all sub-folders, and to access a detailed view of PDF documents within those sub-folders. Altair empowers sponsors to delve deep into their applications, showing them how each sequence impacts the overall submission.
This eagle-eye view of the entire submission helps sponsors navigate through the complexities of regulatory submissions. The viewer's user-friendly interface offers multiple views—Cumulative, Current, and Sequence—each built to provide distinct insights into the submission process. Whether sponsors are loading unlimited sequences in one step or adding sequences as needed, Altair preserves the integrity of eCTD content without any modifications.
eCTD 4.0 is the latest evolution in regulatory submission requirements, with its vigorous tools that manage complex data structures and formats. Being compatible with global regulatory standards, Altair helps sponsors have their submissions accepted and reviewed everywhere.
Altair's powerful functionality also includes the ability to track the history of any document within the submission, offering sponsor.